Artificial Intelligence in Hemophilia Management: Revolutionizing Patient Care and Future Directions
Acta Haematologica · 2025
DOI: 10.1159/000546954 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Acta Haematologica, 2025. Verfasst von Sarina Levy-Mendelovich und 5 weiteren Autor:innen. Beteiligte Einrichtung: National Hemophilia and Thrombosis Center, and Amalia Biron Research Institute of Thrombosis and Hemostasis, Sheba Medical Center, Ramat Gan, Israel. Hauptthemen laut MEDLINE: Hemophilia A, Artificial Intelligence, Patient Care. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background: Recent advancements in artificial intelligence (AI) hold significant promise for transforming hemophilia care. Summary: This review explores the impact of AI on critical aspects of hemophilia management, including bleeding risk prediction, biomarker identification, personalized treatment strategies, and patient education. Key Messages: We discuss the application of machine learning models in predicting bleeding risks among children with hemophilia engaging in physical activities, the use of AI in analyzing factor VIII protein structures to determine disease severity, and the development of AI-powered chatbots and digital platforms for patient education and self-management, particularly in resource-limited settings. Furthermore, we address the challenges inherent in implementing AI technologies in clinical practice, such as data privacy concerns, model interpretability, and the need for robust validation. By highlighting current advancements and future directions, we underscore the potential of AI to enhance personalized care and improve outcomes for individuals with hemophilia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- National Hemophilia and Thrombosis Center, and Amalia Biron Research Institute of Thrombosis and Hemostasis, Sheba Medical Center, Ramat Gan, Israel.
- Gray School of Medicine, Tel Aviv University, Tel Aviv, Israel.
- Talpiot Medical Leadership Program, Sheba Medical Center, Ramat Gan, Israel.
- Windreich Department of Artificial Intelligence and Human Health, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
- Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah-Tikva, Israel.
- Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.
Zitieren
APA
Levy-Mendelovich, S., Glicksberg, B. S., Soffer, S., Gendler, M., Efros, O., & Klang, E. (2025). Artificial Intelligence in Hemophilia Management: Revolutionizing Patient Care and Future Directions. Acta Haematologica. https://doi.org/10.1159/000546954
Vancouver
Levy-Mendelovich S, Glicksberg BS, Soffer S, Gendler M, Efros O, Klang E. Artificial Intelligence in Hemophilia Management: Revolutionizing Patient Care and Future Directions. Acta Haematologica. 2025. doi:10.1159/000546954
BibTeX
@article{LevyMendelovich2025,
author = {Levy-Mendelovich, Sarina and Glicksberg, Benjamin S and Soffer, Shelly and Gendler, Moran and Efros, Orly and Klang, Eyal},
title = {Artificial Intelligence in Hemophilia Management: Revolutionizing Patient Care and Future Directions},
journal = {Acta Haematologica},
year = {2025},
doi = {10.1159/000546954}
}
EUVIMED